Name | Number of supported studies | Average coverage | |
---|---|---|---|
vein endothelial cell | 8 studies | 32% ± 20% | |
endothelial cell of lymphatic vessel | 8 studies | 44% ± 18% | |
endothelial cell | 7 studies | 31% ± 11% | |
oligodendrocyte precursor cell | 7 studies | 24% ± 9% | |
glutamatergic neuron | 4 studies | 38% ± 5% | |
granule cell | 4 studies | 58% ± 19% | |
interneuron | 4 studies | 39% ± 14% | |
mesothelial cell | 4 studies | 23% ± 6% | |
ON-bipolar cell | 3 studies | 29% ± 11% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 29% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 92% | 245.64 | 82 / 89 | 72% | 5.46 | 651 / 901 |
breast | 100% | 948.03 | 457 / 459 | 63% | 2.15 | 705 / 1118 |
prostate | 97% | 337.13 | 237 / 245 | 49% | 0.95 | 244 / 502 |
lung | 96% | 374.54 | 556 / 578 | 38% | 0.99 | 442 / 1155 |
esophagus | 93% | 410.78 | 1339 / 1445 | 36% | 1.78 | 66 / 183 |
uterus | 99% | 468.68 | 169 / 170 | 27% | 1.17 | 123 / 459 |
pancreas | 67% | 119.57 | 219 / 328 | 53% | 1.34 | 95 / 178 |
bladder | 100% | 447.24 | 21 / 21 | 19% | 0.91 | 95 / 504 |
thymus | 100% | 526.03 | 651 / 653 | 18% | 0.28 | 106 / 605 |
intestine | 97% | 400.80 | 941 / 966 | 9% | 0.22 | 49 / 527 |
adipose | 100% | 1035.56 | 1204 / 1204 | 0% | 0 | 0 / 0 |
skin | 87% | 350.66 | 1579 / 1809 | 11% | 0.28 | 53 / 472 |
adrenal gland | 69% | 145.17 | 179 / 258 | 29% | 1.09 | 67 / 230 |
stomach | 62% | 182.95 | 224 / 359 | 17% | 0.35 | 48 / 286 |
brain | 47% | 452.46 | 1254 / 2642 | 22% | 0.69 | 155 / 705 |
blood vessel | 67% | 263.88 | 900 / 1335 | 0% | 0 | 0 / 0 |
heart | 44% | 102.78 | 376 / 861 | 0% | 0 | 0 / 0 |
ovary | 27% | 94.56 | 49 / 180 | 14% | 0.30 | 61 / 430 |
muscle | 24% | 44.01 | 196 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 14% | 0.16 | 4 / 29 |
tonsil | 0% | 0 | 0 / 0 | 11% | 0.45 | 5 / 45 |
liver | 0% | 0.56 | 1 / 226 | 2% | 0.05 | 10 / 406 |
spleen | 2% | 3.56 | 6 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0001501 | Biological process | skeletal system development |
GO_0030199 | Biological process | collagen fibril organization |
GO_0016485 | Biological process | protein processing |
GO_0030154 | Biological process | cell differentiation |
GO_0009953 | Biological process | dorsal/ventral pattern formation |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0004222 | Molecular function | metalloendopeptidase activity |
GO_0005509 | Molecular function | calcium ion binding |
GO_0004252 | Molecular function | serine-type endopeptidase activity |
GO_0008270 | Molecular function | zinc ion binding |
Gene name | TLL1 |
Protein name | Metalloendopeptidase (EC 3.4.24.-) Tolloid like 1 Tolloid-like protein 1 (EC 3.4.24.-) |
Synonyms | TLL |
Description | FUNCTION: Protease which processes procollagen C-propeptides, such as chordin, pro-biglycan and pro-lysyl oxidase. Required for the embryonic development. Predominant protease, which in the development, influences dorsal-ventral patterning and skeletogenesis. |
Accessions | E9PD25 O43897 D6RCE0 ENST00000061240.7 [O43897-1] ENST00000507499.5 D6RAK5 B7ZLW3 ENST00000504560.5 ENST00000509505.5 ENST00000506144.1 D6RBI6 ENST00000513213.5 [O43897-2] |